OFFICIAL PUBLICATION OF

by its subsidiary APPco

Spikevax for younger kids

Megan Haggan 17/02/2022

The TGA has provisionally approved the use of Moderna’s COVID-19 vaccine for children aged six and older The Therapeutic Goods Administration has announced that SPIKEVAX can now be used in individuals aged six and up, following previous approvals for adults and then for children aged 12 and up. “As for other age groups, the use

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Spikevax for younger kids

Previous $1m impact of seized RATs

Next Pharmacy's Got Talent Hall of Fame

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous $1m impact of seized RATs

Next Pharmacy's Got Talent Hall of Fame

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.